PiggyBac-ing models and new therapeutic strategies

Trends in Biotechnology

Volumn 33, Issue 9, 2015, Pages 525-533

  Woodard, Lauren E ^a,b   Wilson, Matthew H ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell therapy; Immunotherapy; IPSC; PiggyBac; Transgenesis; Transposon

Indexed keywords

CYTOLOGY; DNA; DNA SEQUENCES; GENE EXPRESSION; GENE TRANSFER; MAMMALS; STEM CELLS;

CELL THERAPY; IMMUNOTHERAPY; IPSC; PIGGYBAC; TRANSGENESIS; TRANSPOSON;

CELL ENGINEERING;

GENOMIC DNA; TRANSPOSASE;

BACULOVIRIDAE; BIOTECHNOLOGY; CELL ENGINEERING; DNA TRANSPOSITION; DNA VECTOR; GENE DOSAGE; GENE TRANSFER; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; MAMMAL CELL; MOLECULAR THERAPY; MUTAGENESIS; NONHUMAN; NUCLEAR REPROGRAMMING; PIGGYBAC TRANSPOSON; PLASMID; PRIORITY JOURNAL; REVIEW; TRANSGENE; TRANSGENIC ANIMAL; TRANSPOSON; TRICHOPLUSIA NI; ANIMAL; GENE VECTOR; GENETICS; GENOME; MOUSE;

ANIMALIA; MAMMALIA;

ANIMALS; BACULOVIRIDAE; GENETIC ENGINEERING; GENETIC VECTORS; GENOME; HUMANS; MICE;

EID: 84940450173     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2015.06.009     Document Type: Review

References (78)

1. Ivics Z., et al. Molecular reconstruction of Sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997, 91:501-510.
2. Cary L.C., et al. Transposon mutagenesis of baculoviruses: analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology 1989, 172:156-169.
3. Fraser M.J., et al. Assay for movement of Lepidopteran transposon IFP2 in insect cells using a baculovirus genome as a target DNA. Virology 1995, 211:397-407.
4. Ding S., et al. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 2005, 122:473-483.
5. Wilson M.H., et al. PiggyBac transposon-mediated gene transfer in human cells. Mol. Ther. 2007, 15:139-145.
6. Mitra R., et al. piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J. 2008, 27:1097-1109.
7. Woltjen K., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
8. Yusa K., et al. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods 2009, 6:363-369.
9. Rad R., et al. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 2010, 330:1104-1107.
10. Albieri I., et al. A DNA transposon-based approach to functional screening in neural stem cells. J. Biotechnol. 2010, 150:11-21.
11. You L., et al. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 2011, 407:1-6.
12. Wang W., et al. A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cells. Genome Res. 2009, 19:667-673.
13. Kong J., et al. Slingshot: a PiggyBac based transposon system for tamoxifen-inducible 'self-inactivating' insertional mutagenesis. Nucleic Acids Res. 2010, 38:e173.
14. Wu S., et al. Toward simpler and faster genome-wide mutagenesis in mice. Nat. Genet. 2007, 39:922-930.
15. Landrette S.F., et al. piggyBac transposon somatic mutagenesis with an activated reporter and tracker (PB-SMART) for genetic screens in mice. PLoS ONE 2011, 6:e26650.
16. Rad R., et al. A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. Nat. Genet. 2015, 47:47-56.
17. Liang Q., et al. Chromosomal mobilization and reintegration of Sleeping Beauty and PiggyBac transposons. Genesis 2009, 47:404-408.
18. Wang W., et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9290-9295.
19. Jang C.W., Behringer R.R. Transposon-mediated transgenesis in rats. CSH Protoc. 2007, Published online October 1, 2007. 10.1101/pdb.prot4866.
20. Jiang M.G., et al. Generation of transgenic rats through induced pluripotent stem cells. J. Biol. Chem. 2013, 288:27150-32718.
21. Wu Z., et al. Pig transgenesis by piggyBac transposition in combination with somatic cell nuclear transfer. Transgenic Res. 2013, 22:1107-1118.
22. Li Z., et al. Generation of transgenic pigs by cytoplasmic injection of piggyBac transposase-based pmGENIE-3 plasmids. Biol. Reprod. 2014, 90:93.
23. Kahlig K.M., et al. Multiplexed transposon-mediated stable gene transfer in human cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1343-1348.
24. Moriarity B.S., et al. Modular assembly of transposon integratable multigene vectors using RecWay assembly. Nucleic Acids Res. 2013, 41:e92.
25. Li Z., et al. Simple piggyBac transposon-based mammalian cell expression system for inducible protein production. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5004-5009.
26. Balasubramanian S., et al. Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools. J. Biotechnol. 2015, 200:61-69.
27. Tanaka A., et al. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS ONE 2013, 8:e61540.
28. Rostovskaya M., et al. Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res. 2012, 40:e150.
29. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
30. Yu J.Y., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
31. Sommer C.A., et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009, 27:543-549.
32. Kim S.I., et al. KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Stem Cell Rep. 2015, 4:727-743.
33. Okita K., et al. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
34. Kaji K., et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
35. Nagy K., et al. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev. 2011, 7:693-702.
36. Yusa K., et al. Targeted gene correction of alpha(1)-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011, 478:391.
37. Grabundzija I., et al. Comparative analysis of transposable element vector systems in human cells. Mol. Ther. 2010, 18:1200-1209.
38. Doherty J.E., et al. Hyperactive piggyBac gene transfer in human cells and in vivo. Hum. Gene Ther. 2012, 23:311-320.
39. Huang X., et al. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood 2006, 107:483-491.
40. Hackett P.B., et al. A transposon and transposase system for human application. Mol. Ther. 2010, 18:674-683.
41. Nakazawa Y., et al. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J. Immunother. 2009, 32:826-836.
42. Galvan D.L., et al. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J. Immunother. 2009, 32:837-844.
43. Manuri P.V., et al. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum. Gene Ther. 2010, 21:427-437.
44. Heslop H.E., et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood 2010, 115:925-935.
45. Nakazawa Y., et al. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol. Ther. 2011, 19:2133-2143.
46. Huye L.E., et al. Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol. Ther. 2011, 19:2239-2248.
47. Yant S.R., et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 2000, 25:35-41.
48. Nakanishi H., et al. piggyBac transposon-mediated long-term gene expression in mice. Mol. Ther. 2010, 18:707-714.
49. Saridey S.K., et al. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol. Ther. 2009, 17:2115-2120.
50. Liang M., et al. Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis. Am. J. Pathol. 2015, 185:1234-1250.
51. Liang A., et al. Loss of glutathione S-transferase A4 accelerates obstruction-induced tubule damage and renal fibrosis. J. Pathol. 2012, 228:448-458.
52. Matsui H., et al. Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A. PLoS ONE 2014, 9:e104957.
53. Di Matteo M., et al. Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy. Mol. Ther. 2014, 22:1614-1624.
54. Cooney A.L., et al. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon In vivo delivery. Mol. Ther. 2015, 23:667-674.
55. Smith R.P., et al. A hybrid adenoviral vector system achieves efficient long-term gene expression in the liver via piggyBac transposition. Hum. Gene Ther. 2015, 26:377-385.
56. Kim H., Kim J.S. A guide to genome engineering with programmable nucleases. Nat. Rev. Genet. 2014, 15:321-334.
57. Frock R.L., et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 2015, 33:179-186.
58. Fraser M.J., et al. Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect. Mol. Biol. 1996, 5:141-151.
59. Liu G.Y., et al. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J. Gene Med. 2004, 6:574-583.
60. Li X., et al. piggyBac transposase tools for genome engineering. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E2279-E2287.
61. Cadinanos J., Bradley A. Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res. 2007, 35:e87.
62. Kettlun C., et al. Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol. Ther. 2011, 19:1636-1644.
63. Wu S.C., et al. piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15008-15013.
64. Wang H., et al. 'Calling cards' for DNA-binding proteins in mammalian cells. Genetics 2012, 190:941-949.
65. Wilson M.H., George A.L. Designing and testing chimeric zinc finger transposases. Methods Mol. Biol. 2010, 649:353-363.
66. Maragathavally K.J., et al. Chimeric Mos1 and piggyBac transposases result in site-directed integration. FASEB J. 2006, 20:1880-1882.
67. Owens J.B., et al. Chimeric piggyBac transposases for genomic targeting in human cells. Nucleic Acids Res. 2012, 40:6978-6991.
68. Owens J.B., et al. Transcription activator like effector (TALE)-directed piggyBac transposition in human cells. Nucleic Acids Res. 2013, 41:9197-9207.
69. Lacoste A., et al. An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 2009, 5:332-342.
70. Yusa K., et al. A hyperactive piggyBac transposase for mammalian applications. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:1531-1536.
71. Saha S., et al. Evaluating the potential for undesired genomic effects of the piggyBac transposon system in human cells. Nucleic Acids Res 2015, 43:1770-1782.
72. Li X., et al. A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture. Proc Natl Acad Sci USA 2013, 110:E478-E487.
73. Woodard L.E., et al. Comparative analysis of the recently discovered hAT transposon TcBuster in human cells. PLoS ONE 2012, 7:e42666.
74. Li M.A., et al. The piggyBac transposon displays local and distant reintegration preferences and can cause mutations at noncanonical integration sites. Mol. Cell. Biol. 2013, 33:1317-1330.
75. Burnight E.R., et al. A hyperactive transposase promotes persistent gene transfer of a piggyBac DNA transposon. Mol. Ther. Nucleic Acids 2012, 1:e50.
76. Izsvak Z., et al. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol. 2000, 302:93-102.
77. Li M.A., et al. Mobilization of giant piggyBac transposons in the mouse genome. Nucleic Acids Res. 2011, 39:e148.
78. Mates L., et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 2009, 41:753-761.